Camby I - Search Results

1

Anti-galectin compounds as potential anti-cancer drugs.

Ingrassia L, Camby I, Lefranc F, Mathieu V, Nshimyumukiza P, Darro F, Kiss R. Ingrassia L, et al. Among authors: camby i. Curr Med Chem. 2006;13(29):3513-27. doi: 10.2174/092986706779026219. Curr Med Chem. 2006. PMID: 17168720 Review.

2

Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases.

Camby I, Belot N, Lefranc F, Sadeghi N, de Launoit Y, Kaltner H, Musette S, Darro F, Danguy A, Salmon I, Gabius HJ, Kiss R. Camby I, et al. J Neuropathol Exp Neurol. 2002 Jul;61(7):585-96. doi: 10.1093/jnen/61.7.585. J Neuropathol Exp Neurol. 2002. PMID: 12125737

3

Galectins and cancer.

Danguy A, Camby I, Kiss R. Danguy A, et al. Among authors: camby i. Biochim Biophys Acta. 2002 Sep 19;1572(2-3):285-93. doi: 10.1016/s0304-4165(02)00315-x. Biochim Biophys Acta. 2002. PMID: 12223276 Review.

4

Combined cimetidine and temozolomide, compared with temozolomide alone: significant increases in survival in nude mice bearing U373 human glioblastoma multiforme orthotopic xenografts.

Lefranc F, James S, Camby I, Gaussin JF, Darro F, Brotchi J, Gabius J, Kiss R. Lefranc F, et al. Among authors: camby i. J Neurosurg. 2005 Apr;102(4):706-14. doi: 10.3171/jns.2005.102.4.0706. J Neurosurg. 2005. PMID: 15871514

5

Galectin-1 knocking down in human U87 glioblastoma cells alters their gene expression pattern.

Camby I, Decaestecker C, Lefranc F, Kaltner H, Gabius HJ, Kiss R. Camby I, et al. Biochem Biophys Res Commun. 2005 Sep 16;335(1):27-35. doi: 10.1016/j.bbrc.2005.07.037. Biochem Biophys Res Commun. 2005. PMID: 16051185

6

Present and potential future issues in glioblastoma treatment.

Lefranc F, Sadeghi N, Camby I, Metens T, Dewitte O, Kiss R. Lefranc F, et al. Among authors: camby i. Expert Rev Anticancer Ther. 2006 May;6(5):719-32. doi: 10.1586/14737140.6.5.719. Expert Rev Anticancer Ther. 2006. PMID: 16759163 Review.

7

Galectin-1: a small protein with major functions.

Camby I, Le Mercier M, Lefranc F, Kiss R. Camby I, et al. Glycobiology. 2006 Nov;16(11):137R-157R. doi: 10.1093/glycob/cwl025. Epub 2006 Jul 13. Glycobiology. 2006. PMID: 16840800 Review.

8

Galectin-1 is implicated in the protein kinase C epsilon/vimentin-controlled trafficking of integrin-beta1 in glioblastoma cells.

Fortin S, Le Mercier M, Camby I, Spiegl-Kreinecker S, Berger W, Lefranc F, Kiss R. Fortin S, et al. Among authors: camby i. Brain Pathol. 2010 Jan;20(1):39-49. doi: 10.1111/j.1750-3639.2008.00227.x. Epub 2009 Oct 8. Brain Pathol. 2010. PMID: 18947333 Free PMC article.

9

Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration.

Camby I, Belot N, Rorive S, Lefranc F, Maurage CA, Lahm H, Kaltner H, Hadari Y, Ruchoux MM, Brotchi J, Zick Y, Salmon I, Gabius HJ, Kiss R. Camby I, et al. Brain Pathol. 2001 Jan;11(1):12-26. doi: 10.1111/j.1750-3639.2001.tb00377.x. Brain Pathol. 2001. PMID: 11145198 Free PMC article.

10

Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma.

Rorive S, Belot N, Decaestecker C, Lefranc F, Gordower L, Micik S, Maurage CA, Kaltner H, Ruchoux MM, Danguy A, Gabius HJ, Salmon I, Kiss R, Camby I. Rorive S, et al. Among authors: camby i. Glia. 2001 Mar 1;33(3):241-55. doi: 10.1002/1098-1136(200103)33:3<241::aid-glia1023>3.0.co;2-1. Glia. 2001. PMID: 11241742

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

79 results

Search Page